Helical/Arc-Based Radiation Oncology Equipment Assessment
A Survey of Thirty-Five Radiation Oncologists, Five Medical Physicists and Ten Hospital Finance Executives
Price $2500
Deliverable: Survey with key findings.
Study Description:
|
Topic |
Helical/Arc-Based Radiation Oncology Equipment Assessment |
|
Respondent Type |
Radiation Oncologists, Medical Physicists, and Hospital Finance Executives |
|
Specialties Covered |
Oncology |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 30 minutes Size: 50 total respondents Fielding Dates: April 10-15, 2008 |
Objectives:
To gather data related to the purchasing decisions and professional perception of ARC radiation treatment.
§ Determine the current radiation treatment modalities and equipment used by radiation oncologists and medical physicists.
§ Gain insight into current use of and plans to use helical/arc-based treatment platforms by brand.
§ Gauge the future standing of helical therapy within the external beam radiation market.
§ Evaluate respondents’ initial perceptions of the four systems on the market from TomoTherapy, Varian, Elekta, and Siemens.
§ Determine awareness of and assess emerging radiation therapy technologies such as proton-beam radiation therapy and MRI/gamma ray radiotherapy systems.
§ Explore physician perception of current state of hospital equipment financing.
Inclusion Criteria and Respondent Demographics:
|
Inclusion Criteria
|
§ Radiation oncologists and medical physicists o Involved in purchasing decisions for radiation oncology equipment o Treating patients with external beam radiation for at least 2 years o Treat at least 1 patient per week with external beam radiation o Familiar with helical/arc-based treatment platforms o Used or evaluated one of the four software packages listed: Siemens, Elekta, TomoTherapy, or Varian Medical Systems § Hospital finance executives o Involved in purchasing decision for radiation oncology equipment o Familiar with municipal bonds/auction rate securities |
To purchase this report or request additional information, contact:
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |